{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-24-000084","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.667502+00:00","generated_at":"2026-05-30T10:20:10.323273+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Edwards Q3 sales up 9% to $1.33B; TAVR +6%, TMTT +73%; adjusted EPS $0.67 beats guidance","bullets":["Q3 sales from continuing ops $1.33B (+9% as-reported, +10% constant currency); adjusted EPS $0.67 ahead of July guidance.","TAVR sales $1.0B (+6% reported, +7% constant currency); TMTT sales $91M (+73%) driven by PASCAL and EVOQUE launches.","GAAP EPS $5.13 includes one-time gain from sale of Critical Care unit; adjusted gross margin 80.7% vs 79.9% last year.","Repurchased $1.0B of stock in Q3; remaining authorization $1.4B; cash $3.5B, debt $600M.","Reiterated FY2024 total sales growth 8-10%; Q4 guidance: sales $1.33-1.39B, EPS $0.53-0.57."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-24-000084","json":"https://secwatch.observer/filing/0001099800-24-000084.json","markdown":"https://secwatch.observer/filing/0001099800-24-000084.md","text":"https://secwatch.observer/filing/0001099800-24-000084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000084/0001099800-24-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000084/ew-20241024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:20:10.323273+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}